No Data
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○List of stocks converting to Sell Market Code Stock Name Closing Price SAR Main Board <1720> Tokyu Construction 700 715 <1803> Shimizu Construction 1215 1248 <1878> Daito Construction 1767 518225 <1882> Toa Road 1280 1311 <1925> Daiwa House 4717 4849 <1928> Sekisui House 3579 3730 <1934> Euretec 1436 1472 <1952
Nikkei Average Contribution Ranking (pre-close) ~ The Nikkei Average has fallen for four consecutive days, and SoftBank Group has pushed it down by about 66 yen for one stock.
As of the close on 18 days ago, the number of rising and falling stocks in the Nikkei average was 116 stocks up, 108 stocks down, and 1 stock unchanged. The Nikkei average has declined for four consecutive days. It ended the morning trading at 39,281.06 yen, down 83.62 yen (-0.21%) from the previous day (with an estimated Volume of 1.1 billion 60 million shares). On the 17th, the US stock market fell. The Dow Inc. decreased by 267.58 dollars to 43,449.90 dollars, and the Nasdaq dropped by 64.83 points to 20,109.06.
ADR Japanese stock ranking - mixed highs and lows, Chicago is up 165 yen compared to Osaka at 39,625 yen.
Regarding Japanese stocks of American Depositary Receipts (ADR), when compared to the Tokyo Stock Exchange (calculated at 154.13 yen per dollar), companies like SoftBank Group Corp <9984>, Toyota Industries <6201>, Disco <6146>, Tokyo Electron <8035>, Renesas <6723>, and Mizuho Financial Group <8411> saw an increase, while others like Japan Post Bank <7182>, Mitsubishi UFJ Financial Group <8306>, Murata Manufacturing <6981>, Chugai Pharmaceutical <4519>, Nidec <6594>, and Sony Group Corp <6758> experienced a decline, overall.
Fanpeep --- Submission of the clinical trial plan for the additional Phase III clinical trial of the functional peptide "SR-0379."
Fanpep <4881> announced on the 9th that it submitted a clinical trial plan for an additional Phase 3 clinical trial (SR0379-JP-SU-02 trial, hereinafter referred to as the 02 trial) for the functional peptide "SR-0379," which is being developed for the treatment of skin ulcers, to the Pharmaceuticals and Medical Devices Agency (hereinafter referred to as PMDA) on December 6, aiming for early approval. The 02 trial is expected to start following PMDA's designated investigation.
Emerging Markets stock digest: INGS continues to rise significantly, while R Planner soars.
＜245A＞ INGS 2575 +114 significantly continued to rise. After the market closed yesterday, the fast report on direct store revenue for the period ending in August 2025 was released. Same-store sales for the ramen business increased by 7.8% year-on-year, and the restaurant business increased by 9.7%, continuing to show an increasing revenue trend. As of the end of November 2024, there are 32 direct stores in the ramen business (an increase of 4 stores) and 32 stores in the restaurant business (an increase of 4 stores). In November, the same-store results for the ramen business continued.
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○ List of stocks for buy transition market Code Stock Name Final Price SAR Main Board <1835> Tokyo Steel 3245 3105 <1878> Daito Construction 1742016670 <1884> Nihon Road 17521647 <1887> Japan National Land Development 511487 <1942> Kansai Electric Works 22532128 <1959> Kyushu Electric Industry 51715026 <2389> Digital HD 12681234 <2579>
No Data
